Iqvia launches new eCOA platform to quantify the patient experience
As the pharmaceutical industry adopts a more patient-centric view of treatment benefits for new drugs, capturing their experience and integrating feedback into trial design is now a must.
“Collecting direct-from-patient data allows sponsors to strengthen traditional measures and better address patients’ concerns about their experience, which can increase the likelihood of drug approval,” said Eric Hodgins, senior vice president, real world and analytics solutions (RWAS) technologies at Iqvia.
The new electronic clinical outcome assessment (eCOA) cloud-based technology platform was released today during the DIA Global Annual Meeting in San Diego, CA. According to the company, the solution is “a science and technology-enabled approach that captures quantified evidence of patients’ experiences during clinical trials and real world studies.”
Hodgins told us the platform enables trial sponsors to better understand – and improve – the patient experience. “The technology features a simple and intuitive interface providing advanced patient assessments that enhance the patient experience and improve data quality – amplifying the patient’s voice to accelerate outcomes,” he explained.
The main benefits include reduced timelines, increased efficiency, improved data transparency, and real-time insights about patients, said Hodgins, adding that the product’s key differentiator is its “unparalleled configurability.”
“We flipped the traditional software development lifecycle upside down. This process was cumbersome and required development teams to interpret massive design requirement documents, which typically created cycles of rework and potential for errors,” Hodgins said.
“Our solution brings the clinical trial team, who are typically not technical experts, together and allows them to design and adjust the eCOA solution in real-time,” he explained. Study teams also can preview the solution on multiple devices at the same time to identify any errors in real-times.
Additionally, the platform features Iqvia’s expanding patient questionnaires library, which lets customers use pre-built and validated assessments for their study.
